16 November - 17 November 2020

3rd SCI-RSC Symposium on Antimicrobial Drug Discovery

Organised by:

SCI’s Fine Chemicals Group and RSC’s Biological and Medicinal Chemistry Sector

London, UK

Register your Interest
Synopsis

At a time when antimicrobial resistance is decreasing the efficacy of existing treatments, it has never been more important that we refresh the drug pipeline with new therapeutics acting on new targets or exhibiting novel modes of action.
Fortunately, renewed interest from both industry and academia has led to a resurgence in antimicrobial drug discovery and interest in developing innovative technologies and approaches for combating infection.

Coinciding with WHO’s World Antibiotics Awareness week, this two-day meeting will examine the latest advances in antimicrobial drug discovery from a medicinal chemist’s perspective, focusing on the particular challenges associated with developing antimicrobials whilst also showcasing emerging strategies for tackling infection.


Attendees
Bringing together leading exponents in the field from industry and academia, the meeting will appeal to anyone with an interest in antimicrobial resistance and antimicrobial drug discovery.  And with great opportunities for academic–industrial partnerships, researchers from both sectors will also benefit from the networking opportunities that the meeting will offer.

Programme
Target-based anti-infective discovery
Prof Dr Anna Hirsch, Helmholtz Institute of Pharmaceutical Research, Saarland, Germany
Synthesis and mechanistic evaluation of gram-negative selective antimicrobial lipopeptides that target the bacterial cell wall
Dr Stephen Cochrane, Queen's University Belfast, Northern Ireland
Tackling the threat of NDM-mediated resistance: SAR leading to the identification of a preclinical candidate metallo beta-lactamase inhibitor, ANT2681
Dr David Davies, Antabio, France
Filling the gaps in Gram-negative antibacterial drug discovery: GARDP's approach
Dr Benjamin Blasco, Discovery Senior Project Manager, GARDP, Geneva, Switzerland
Discovery of novel non-beta-lactam PBP inhibitors to treat pseudomonas aeruginosa infections
Dr Thomas Durand-Reville, Entasis Therapeutics, USA
Keynote speaker: The truth is out there: nature as a source of new antimicrobials and alternatives
Prof Gerry Wright, McMaster University, Canada    
Outer membrane protein targeting antibiotics against WHO priority 1 Gram-negative bacteria
Dr Daniel Obrecht, Polyphor, Switzerland
Talk title to be confirmed
Dr Danny O'Hare, Imperial College London, UK
Tethered peptide macrocycles, a novel antibiotic class targeting Acinetobacter baumannii;
Dr Patrizio Mattei, Roche, Switzerland
The discovery of relebactam (MK-7655): A β-Lactamase Inhibitor FDA approved for combination with the carbapenem antibiotic primaxin;
Dr Jason Imbriglio, Director – Chemical Biology, Merck, USA
Talk title to be confirmed
Prof William Hope, University of Liverpool, UK
Discovery of PC945, a novel antifungal agent for inhaled administration
Dr Mihiro Sunose, Sygnature Discovery, UK
Talk title to be confirmed
Speaker TBC, Shionogi Pharmaceutical Research Centre, Japan
Talk title to be confirmed
Andrew Shaw, University of Exeter and Attomarker Ltd    


Call for Short-Talks from Early-Career Researchers

Early-career researchers wishing to give a short talk are encouraged to submit a one-page abstract to conferences@soci.org by Friday 25 September 2020 with "AM-III – short talk abstract" in the subject line. Early submissions are welcomed and advisable for delegates who may need extra time to apply for a visa to attend the meeting.

 


Call for Posters and Flash Presentations

Anyone wishing to present a poster should submit a one-page abstract to conferences@soci.org by Friday 25 September 2020 with "AM-III – poster abstract" in the subject line.  Selected poster presenters will have the opportunity to give a flash presentation. Early submissions are welcomed and advisable for delegates who may need extra time to apply for a visa to attend the meeting.

 


 Exhibition & Sponsorship

An exhibition will take place alongside the conference during refreshment breaks for companies and related organisations who may wish to exhibit. For further information and prices, please email conferences@soci.org. Spaces are limited and will be allocated on a first come, first served basis.

 


Venue and Contact

SCI

14/15 Belgrave Square
London
SW1X 8PS

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org


Booking Process

Read our event booking terms and conditions


Partners

Exhibitors

Organising Committee
  • Dr Liam Cox, SCI / University of Birmingham
  • Dr Caroline Low, SCI / Computational Medicinal Chemistry Consultant
  • Dr Pascal Savy, SCI / Charles River Laboratories
  • Dr Francis Wilson, RSC / Summit Therapeutics